Cetera Investment Advisers
REGN icon

Cetera Investment Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History

Cetera Investment Advisers’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.14M Sell
14,664
-1,342
-8% -$913K 0.01% 1216
2026
Q1 		$12.4M Buy
16,006
+198
+1% +$152K 0.01% 950
2025
Q4 		$12.2M Sell
15,808
-241
-2% -$164K 0.01% 914
2025
Q3 		$9.02M Buy
16,049
+6,295
+65% +$3.56M 0.01% 1051
2025
Q2 		$5.12M Sell
9,754
-821
-8% -$458K 0.01% 1174
2025
Q1 		$6.71M Buy
10,575
+1,336
+14% +$919K 0.01% 954
2024
Q4 		$6.58M Buy
9,239
+494
+6% +$415K 0.01% 902
2024
Q3 		$9.19M Buy
8,745
+799
+10% +$889K 0.02% 735
2024
Q2 		$8.35M Sell
7,946
-1,807
-19% -$1.75M 0.02% 746
2024
Q1 		$9.39M Buy
9,753
+5,955
+157% +$5.66M 0.02% 692
2023
Q4 		$3.34M Buy
3,798
+118
+3% +$97.2K 0.03% 590
2023
Q3 		$3.03M Sell
3,680
-114
-3% -$89.6K 0.03% 594
2023
Q2 		$2.73M Buy
3,794
+90
+2% +$69.4K 0.02% 640
2023
Q1 		$3.04M Buy
3,704
+509
+16% +$384K 0.03% 566
2022
Q4 		$2.31M Buy
3,195
+1,771
+124% +$1.31M 0.02% 650
2022
Q3 		$981K Sell
1,424
-1,315
-48% -$828K 0.02% 725
2022
Q2 		$1.62M Sell
2,739
-282
-9% -$183K 0.03% 608
2022
Q1 		$2.11M Sell
3,021
-62
-2% -$39.2K 0.03% 546
2021
Q4 		$1.95M Buy
3,083
+459
+17% +$282K 0.03% 561
2021
Q3 		$1.59M Buy
2,624
+54
+2% +$33.5K 0.03% 604
2021
Q2 		$1.44M Sell
2,570
-189
-7% -$95.8K 0.02% 636
2021
Q1 		$1.3M Buy
2,759
+483
+21% +$235K 0.03% 564
2020
Q4 		$1.1M Buy
+2,276
New +$1.23M 0.02% 632

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cetera Investment Advisers's REGN Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Regeneron Pharmaceuticals (REGN) stake by 8.4% in Q2 2026, selling an estimated $913K and leaving 14,664 shares worth $9.14M. The position accounts for 0.01% of the portfolio, ranked #1216.

Cetera Investment Advisers first reported a position in REGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $12.4M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Cetera Investment Advisers held 14,664 shares of Regeneron Pharmaceuticals worth $9.14M as of Q2 2026.
  • Cetera Investment Advisers sold 1,342 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $913K.
  • Regeneron Pharmaceuticals made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1216 holding.
  • Cetera Investment Advisers first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Cetera Investment Advisers's Regeneron Pharmaceuticals position peaked at $12.4M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.